St. Jude Medical, Inc. (STJ) Reports Mostly Inline Q2 Results; Guides Q3, FY11 EPS
Tweet Send to a FriendGet Alerts STJ Hot Sheet
Price: $45.15 -0.04%
Revenue Growth %: -4.3%
Financial Fact:
Net sales: 1.34B
Today's EPS Names:
ANF, DXLG, FL, More
Revenue Growth %: -4.3%
Financial Fact:
Net sales: 1.34B
Today's EPS Names:
ANF, DXLG, FL, More
Trade STJ Now!
St. Jude Medical, Inc. (NYSE: STJ) reported Q2 EPS of $0.85, $0.01 better than the analyst estimate of $0.84. Revenue for the quarter came in at $1.45 billion versus the consensus estimate of $1.45 billion.
Sees Q3 2011 EPS of $0.74-$0.76, versus the consensus of $0.80.
Sees FY2011 EPS of $3.25-$3.30, versus the consensus of $3.30.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Sees Q3 2011 EPS of $0.74-$0.76, versus the consensus of $0.80.
Sees FY2011 EPS of $3.25-$3.30, versus the consensus of $3.30.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Marvell Technology Group (MRVL) Tops Q1 EPS by 5c; Issues Solid Outlook
- salesforce.com, Inc. (CRM) Reports In-Line Q1 EPS; Issues In-Line Q2, FY14 Outlook
Create E-mail Alert Related Categories
Earnings, Guidance
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
